JP2026026084A5 - - Google Patents
Info
- Publication number
- JP2026026084A5 JP2026026084A5 JP2025179886A JP2025179886A JP2026026084A5 JP 2026026084 A5 JP2026026084 A5 JP 2026026084A5 JP 2025179886 A JP2025179886 A JP 2025179886A JP 2025179886 A JP2025179886 A JP 2025179886A JP 2026026084 A5 JP2026026084 A5 JP 2026026084A5
- Authority
- JP
- Japan
- Prior art keywords
- heavy chain
- variant
- variable region
- chain variable
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2027891 | 2021-03-31 | ||
| NL2027891 | 2021-03-31 | ||
| JP2023560715A JP7850884B2 (ja) | 2021-03-31 | 2022-03-30 | 新規多重特異性抗体 |
| PCT/NL2022/050174 WO2022211625A1 (en) | 2021-03-31 | 2022-03-30 | Novel multispecific antibodies |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560715A Division JP7850884B2 (ja) | 2021-03-31 | 2022-03-30 | 新規多重特異性抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026026084A JP2026026084A (ja) | 2026-02-16 |
| JP2026026084A5 true JP2026026084A5 (https=) | 2026-04-28 |
Family
ID=76035095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025179886A Pending JP2026026084A (ja) | 2021-03-31 | 2025-10-24 | 新規多重特異性抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240309115A1 (https=) |
| EP (1) | EP4314061A1 (https=) |
| JP (1) | JP2026026084A (https=) |
| KR (1) | KR20230165256A (https=) |
| CN (2) | CN118165116A (https=) |
| AU (1) | AU2022251985A1 (https=) |
| BR (1) | BR112023020141A2 (https=) |
| CA (1) | CA3213796A1 (https=) |
| IL (1) | IL307332A (https=) |
| MX (1) | MX2023011362A (https=) |
| PH (1) | PH12023552704A1 (https=) |
| TW (1) | TW202302630A (https=) |
| WO (1) | WO2022211625A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220380440A1 (en) * | 2018-12-31 | 2022-12-01 | Merus N.V. | Truncated multivalent multimers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2838917T1 (sl) | 2012-04-20 | 2019-11-29 | Merus Nv | Postopki in sredstva za produkcijo heterodimernih IG-podobnih molekul |
| TWI773646B (zh) * | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| BR112019005895A2 (pt) | 2016-09-23 | 2019-06-11 | Merus N.V. | moléculas de ligação que modulam uma atividade biológica expressa por uma célula |
| EA202090003A1 (ru) | 2017-07-06 | 2020-06-18 | Мерус Н.В. | Связывающие молекулы, модулирующие биологическую активность, которую проявляет клетка |
| EA202090005A1 (ru) | 2017-07-06 | 2020-06-18 | Мерус Н.В. | Антитела, модулирующие биологическую активность, проявляемую клеткой |
| KR102666754B1 (ko) * | 2018-08-21 | 2024-05-17 | 에이비엘바이오 주식회사 | 항-pd-l1/항-lag3 이중 특이 항체 및 이의 용도 |
| KR20220008316A (ko) * | 2019-05-14 | 2022-01-20 | 에프-스타 테라퓨틱스 리미티드 | Lag-3/pd-l1 이중특이적 항체의 투여를 위한 투여 요법 |
| EP3983450A4 (en) * | 2019-06-12 | 2023-07-05 | Nanjing GenScript Biotech Co., Ltd. | ANTI-PD-L1/ANTI-LAG-3 PROTEINS WITH MULTIPLE ANTIGEN BINDING AND METHODS FOR THEIR USE |
-
2022
- 2022-03-30 AU AU2022251985A patent/AU2022251985A1/en active Pending
- 2022-03-30 WO PCT/NL2022/050174 patent/WO2022211625A1/en not_active Ceased
- 2022-03-30 EP EP22714634.7A patent/EP4314061A1/en active Pending
- 2022-03-30 TW TW111112288A patent/TW202302630A/zh unknown
- 2022-03-30 MX MX2023011362A patent/MX2023011362A/es unknown
- 2022-03-30 CN CN202410306860.1A patent/CN118165116A/zh active Pending
- 2022-03-30 BR BR112023020141A patent/BR112023020141A2/pt not_active Application Discontinuation
- 2022-03-30 KR KR1020237034870A patent/KR20230165256A/ko active Pending
- 2022-03-30 US US18/553,114 patent/US20240309115A1/en active Pending
- 2022-03-30 PH PH1/2023/552704A patent/PH12023552704A1/en unknown
- 2022-03-30 CN CN202280026434.1A patent/CN117157323A/zh active Pending
- 2022-03-30 IL IL307332A patent/IL307332A/en unknown
- 2022-03-30 CA CA3213796A patent/CA3213796A1/en active Pending
-
2025
- 2025-10-24 JP JP2025179886A patent/JP2026026084A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI828767B (zh) | 抗ｈｌａ－ｇ抗體、包含抗ｈｌａ－ｇ抗體之組成物及使用抗ｈｌａ－ｇ抗體之方法 | |
| JP2022068161A (ja) | 新規抗ｐｄ－ｌ１抗体 | |
| JP2018533371A5 (https=) | ||
| JP2018532383A5 (https=) | ||
| JP2017530722A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP2020516240A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2018508483A5 (https=) | ||
| IL253462B (en) | Cancer treatment with monoclonal antibodies against latency-associated peptide | |
| JP2014511179A5 (https=) | ||
| JP2014509510A5 (https=) | ||
| JP2026026084A5 (https=) | ||
| US20240101675A1 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof | |
| US20250179195A1 (en) | Anti-flt3 antibodies and compositions | |
| JP2025118688A5 (https=) | ||
| JPWO2022044573A5 (https=) | ||
| IL277899B1 (en) | Methods and compositions for treating yellow fever | |
| JPWO2020257289A5 (https=) | ||
| CA3213682A1 (en) | Multispecific binding moieties comprising novel pd-1 binding domains | |
| CA3211727A1 (en) | Novel pd-1 binding domains | |
| WO2022121846A1 (zh) | Pd-l1抗体及其应用 | |
| RU2810326C2 (ru) | Антитела против hla-g, композиции, содержащие антитела против hla-g, и способы применения антител против hla-g | |
| WO2023125483A1 (zh) | 一种抗tnfr2抗体药物组合物 | |
| HK40106092A (zh) | 抗nkg2a抗体和组合物 |